SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- and long-acting insulins.
Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials have found. Photo by Adobe Stock/HealthDay News Weekly insulin shots can ...
Insulin therapy helps control blood sugar levels in diabetes. What type of insulin you take, how often you take it, and how it’s administered are all part of your individualized treatment plan. For ...
Researchers compared the efficacy of once-weekly and once-daily insulin treatments for type 2 diabetes. They found that the once-weekly treatment icodec was more effective in lowering blood sugar ...
People with Type 2 diabetes could soon have access to convenient once-a-week insulin shots that could replace the daily injections now required. A once-weekly insulin formulation called icodec ...
Insulin icodec, a once-weekly basal injection to treat type 1 diabetes, has the potential to be as effective in managing the condition as daily basal insulin treatments, according to new research. The ...
Insulin pumps provide better blood sugar control for adults with diabetes than multiple daily insulin injections, a new study says. Insulin pumps are small devices that are worn by patients and ...
Scientists have designed a new type of oral capsule that could mean pain-free delivery of insulin and other protein drugs. Protein drugs had proven challenging to deliver orally as the drugs degrade ...
More than 37 million people in the U.S. have diabetes. According to the American Diabetes Association, 8.4 million Americans needed to take insulin in 2022 to lower their blood sugar. Insulin, however ...
Data were obtained through an Internet survey of U.S. adults self-identified as taking insulin to treat type 1 or type 2 diabetes; the survey was conducted 13 June to 7 July 2008 by Harris Interactive ...
Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials have found. A new class of insulin called efsitora alfa has been ...